Zoledronic Acid Injection, Solution
Product Images NDC 68083-135

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 68083-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zoledronic-spl-carton (Zoledronic Spl Carton)

This text contains information about a medication called "Zoledronic Acid Injection" which is administered through intravenous infusion. It comes in a single-dose vial of 100 mL with a concentration of 5 mg per 100 mL. There are also references to a medication guide which is provided to each patient.*

FDA Label Image

Zoledronic-spl-container (Zoledronic Spl Container)

FDA Label Image

Zoledronic-spl-structure (Zoledronic Spl Structure)

FDA Label Image

Zoledronic-spl-graph1 (Zoledronic Spl Graph1)

FDA Label Image

Zoledronic-spl-graph2 (Zoledronic Spl Graph2)

Therapeutic response over time is being evaluated, specifically the normalization of serum alkaline phosphatase (SAF) levels over a period of time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.